Published in Cancer Epidemiol on October 22, 2016
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85
The global health burden of infection-associated cancers in the year 2002. Int J Cancer (2006) 13.57
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol (2012) 6.05
Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer (2009) 4.28
Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer (2004) 3.40
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol (2014) 2.41
Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health (2009) 2.01
A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol (2002) 1.90
Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control (2008) 1.89
Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.81
Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol (2012) 1.78
Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol (2009) 1.77
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer (1999) 1.70
Updating the natural history of human papillomavirus and anogenital cancers. Vaccine (2012) 1.65
Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: the ARCAGE study. Oral Oncol (2014) 1.52
Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) (2012) 1.46
Epidemiologic study on penile cancer in Brazil. Int Braz J Urol (2008) 1.45
Cancer of the anal canal. Lancet Oncol (2004) 1.40
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer (2014) 1.40
Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer (2013) 1.38
The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine (2013) 1.18
HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agent Cancer (2011) 1.16
Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer (2008) 1.12
Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health (2016) 1.08
Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer (2010) 0.96
Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study. Infect Agent Cancer (2014) 0.95
Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? Oral Oncol (2014) 0.93
Foods, nutrients and the risk of oral and pharyngeal cancer. Br J Cancer (2013) 0.90
The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening. Obstet Gynecol Int (2013) 0.88
Detection of Human papillomavirus and cellular regulators p16INK4a, p53, and NF-kappaB in penile cancer cases in Kenya. Acta Virol (2009) 0.88
Prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Enugu, South-eastern Nigeria. J Obstet Gynaecol (2011) 0.85
Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol (2015) 0.83
Pattern of primary gynecological malignancies as seen in a tertiary hospital situated in the Rivers State of Nigeria. Int J Gynaecol Obstet (1990) 0.82
Cancer and HIV infection in referral hospitals from four West African countries. Cancer Epidemiol (2015) 0.82
Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria. PLoS One (2016) 0.81
Human papillomavirus genotypes in a subset of head and neck squamous cell carcinoma. West Afr J Med (2014) 0.81
The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol (2009) 0.80
Oral and oropharyngeal cancer and the role of sexual behaviour: a systematic review. Community Dent Oral Epidemiol (2016) 0.79
Oncogenic viral prevalence in invasive vulvar cancer specimens from human immunodeficiency virus-positive and -negative women in Botswana. Int J Gynecol Cancer (2014) 0.79
Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines. Cancer (2016) 0.78
[Occupational exposure and cancer of the oral cavity and pharynx]. Laryngorhinootologie (2002) 0.78
Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma. Cancer Lett (2008) 0.77
Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J (2015) 0.76
The clinicopathologic spectrum of anal cancer in KwaZulu-Natal Province, South Africa: Analysis of a provincial database. Cancer Epidemiol (2015) 0.76
Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer Registries. Front Public Health (2015) 0.76
The Benefits of Providing External Beam Radiotherapy in Low- and Middle-income Countries. Clin Oncol (R Coll Radiol) (2016) 0.75